GeneDx Holdings - Rising Test Volumes Provide Strong Outlook!

Business drivers: GeneDx Holdings Corp. (DGS) is one of the leading providers of genomic testing for rare genetically caused diseases. Thanks to the world-leading database with over 850,000 genomes and exomes from GeneDx Holdings, rare and hereditary diseases can be diagnosed significantly earlier and more reliably. As the number of gene and exome tests increases significantly, the outlook for GeneDX is also improving. On July 30, GeneDx Holdings surprised with a better-than-expected Q2 result. The adjusted earnings per share were 50 cents,...